Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

NCT00814593 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Hoag Hospital ceased support.

Conditions

Brain and Central Nervous System Tumors

Interventions

BIOLOGICAL: lymphokine-activated killer cells
DRUG: polifeprosan 20 with carmustine implant

Sponsor

Lisata Therapeutics, Inc.